Van Gerwen joined Dow in 2007 as the Strategic Planner for Rohm and Haas’s European, Middle East and Africa (EMEA) region, after working for a number of chemical companies in positions of increasing responsibility. He joined Dow Microbial Control in 2009 as Global Commercial Director and helped that business move successfully into the fast-growing shale gas business. In 2011, he joined Dow Wolff Cellulosics as Global Marketing and Sales Leader. Van Gerwen succeeds Martin Sonntag, who is leaving Dow for a position outside the organization. “Martin will always hold a special place in our hearts,” said Carr. “He understands the need to be market-driven, and began the business transition that Marc takes over today. We thank him sincerely for his contributions.”About Dow Pharma & Food Solutions Dow Pharma & Food Solutions designs differentiated solutions that enable pharmaceutical delivery & nutritional benefits to customers around the world. Formerly known as Dow Wolff Cellulosics, this business continues to efficiently and reliably manage the manufacturing assets for high-performance cellulose derivatives and companion chemistries used for formulating solutions across a broad variety of applications, including auto-honeycomb and other industrial applications. Cellulosics and their derivatives are produced from renewable raw materials, mainly wood pulp and cotton, sourced primarily from suppliers that implement certified sustainable forestry practices. Dow Pharma & Food Solutions employs 1,200 people across nine sites and 15 manufacturing plants, with six cGMP's, serving customers in around 160 countries. Additional details can be found at www.dowwolff.com. About Dow Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company connects chemistry and innovation with the principles of sustainability to help address many of the world's most challenging problems such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity. Dow's diversified industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 160 countries and in high growth sectors such as electronics, water, energy, coatings and agriculture. In 2012, Dow had annual sales of approximately $57 billion and employed approximately 54,000 people worldwide. The Company's more than 5,000 products are manufactured at 188 sites in 36 countries across the globe. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com. ®Trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow
The Dow Chemical Company (NYSE:DOW) today announced that Marc van Gerwen has been named Global Business Director for Dow Pharma & Food Solutions. This business has been formerly known as Dow Wolff Cellulosics.
Marc van Gerwen, Global Business Director, Dow Pharma & Food Solutions (Photo: Business Wire)Dow Pharma & Food Solutions uses natural, plant-based cellulosic technology and companion chemistries to serve the needs of the fast-growing healthcare and medical markets, and to help make everyday foods a little tastier and healthier for consumers. This business also continues to cherish its foundational industrial applications, such as auto-honeycomb and anti-static films as well as conductive pastes for photovoltaic applications. “This is a business built around helping solve some of the world’s most challenging problems,” said van Gerwen, who is based in Horgen, Switzerland, and assumed the leadership role in late February. “We help bring food to the table that tastes great, but perhaps has a little less fat in it, or gives the consumer that satisfied feeling with smaller amounts of food. We also make high-quality pharmaceutical ingredients designed to help get healing medications to the right part of the body at the right time in the right dosage. “Our customers count on us to continually develop customized solutions to meet their needs and keep them competitive,” continued van Gerwen. “Understanding customer needs has been at the heart of our business for more than 40 years. We will continue to partner with them to help design even more impactful solutions, such as our new AFFINISOL TM solubilization excipients.” “Marc is the right person for the job,” said Neil Carr, Business President for Functional Materials. “After two years as Marketing and Commercial Director, he knows the business, and many of its customers. He has a demonstrated talent for working closely with them to get good results for all.” Dow Pharma & Food Solutions is one of four business units within Dow’s Functional Materials business group.